Lanzamiento Enero 2027

Ensayo controlado aleatorizado2026Financiación no declaradaAcceso abierto

Effectiveness of a novel low-level laser therapy protocol in managing breast cancer-related lymphedema

Yoon JA, Bae H, Choi SH, Rhee MH, Kim YJ, Kong IJ, Lim HJ, Jeon JY

Lasers in medical science · 0 citas

Etiquetas de revisión

Financiación no declarada

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2026-09-24 · Lasers Med Sci · vol. 41 · número 1
Editorial
Springer Science+Business Media
Citado
0 citas · más que el 77% de estudios similares · 0.0× el promedio de su campo
Referencias
24 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC-ND
Áreas de investigación
Laser Applications in Dentistry and Medicine · Lymphatic System and Diseases · Dermatologic Treatments and Research
Palabras clave
low-level laser therapy, breast cancer-related lymphedema, 650 nm wavelength, shear wave elastography, tissue stiffness, dermal backflow, lymphatic dysfunction, extracellular volume, tissue dielectric constant, decongestive therapy
MeSH
humans, breast neoplasms, lymphography, treatment outcome, adult, aged, middle aged, female, elasticity imaging techniques, low-level light therapy, breast cancer lymphedema

8 autores

  • Jin A Yoon🇰🇷Pusan National University Hospital; Pusan National University
  • Hasuk Bae🇰🇷Ewha Womans University; Ewha Womans University Mokdong Hospital
  • Su Hong Choi🇰🇷Pusan National University Hospital
  • Min-Hyung Rhee🇰🇷Pusan National University Hospital
  • Ye Ji Kim🇰🇷Pusan National University Hospital
  • In Joo Kong🇰🇷Pusan National University Hospital
  • Hyo Jeong Lim🇰🇷Pusan National University Hospital
  • Jae Yong Jeon🇰🇷 · autor de correspondenciaAsan Medical Center; University of Ulsan

Resumen

El texto original del estudio, en el idioma en que se publicó.

In this study, we investigate the effects of low-level laser therapy (LLLT) at different wavelengths on lymphedema to further determine the appropriate protocol and effectiveness of LLLT in patients with breast cancer-related lymphedema (BCRL). A randomized controlled trial was conducted involving 46 patients with BCRL. Participants were assigned to receive 904 nm LLLT, 650 nm LLLT, or sham treatment. ICG lymphography was used to assess dermal backflow as a marker of lymphatic dysfunction. Ultrasonography was used to assess subcutaneous thickness and tissue mechanical properties; shear wave velocity (SWV), with higher values indicating greater tissue stiffness, was measured using shear wave elastography. Extracellular fluid volume and local tissue water content were evaluated using multifrequency bioelectrical impedance analysis (MFBIA) and tissue dielectric constant (TDC), respectively. No significant between-group differences were observed in ICG lymphography, MFBIA, or TDC outcomes. For ultrasonographic outcomes, the overall between-group difference in the change in upper-lateral SWV ratio was significant (p = 0.029), and Bonferroni-adjusted post-hoc analysis showed a greater reduction in Group A (904 nm) than in Group B (650 nm) (adjusted p = 0.026). Within Group A, SWV ratios decreased significantly at the lower-lateral site and at the LLLT treatment site. These site-specific findings were not accompanied by measurable changes in lymphatic transport or fluid-related outcomes. Adding 904 nm-650 nm LLLT to conventional decongestive therapy did not produce significant additional effects on extracellular fluid-related or lymphatic functional outcomes. Site-specific reductions in SWV observed with 904 nm LLLT suggest a potential wavelength-dependent effect on local tissue mechanical properties; however, these findings are limited and should be considered exploratory. Larger adequately powered studies with prespecified primary outcomes and longer follow-up are required.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.